UnitedHealth raises 2026 outlook: what it means for UnitedHealth Group stock

Published on 10/19/2026 at 09:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 revenue reached USD 112.69 billion and adjusted EPS was USD 4.69. UnitedHealth Group stock costs EUR 357.00 on October 19, 2026 versus EUR 356.60.

Guidance and quarterly evidence

UnitedHealth raised adjusted 2026 earnings guidance from USD 19.50-20.00 to at least USD 20.50 on October 13, 2026.
Third-quarter revenue reached USD 112.69 billion against USD 111.31 billion expected.
UnitedHealth Group stock trades at EUR 357.00 at 8:58 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.11 percent above the Xetra close of October 16, 2026.

UnitedHealth Group, US91324P1021, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) was trading pre-market at EUR 357.00 at Lang & Schwarz on October 19, 2026, 0.11 percent above the Xetra close of October 16, 2026 at EUR 356.60. The insurer raised its adjusted 2026 earnings outlook after third-quarter results on October 13, 2026, a move detailed by Yahoo Finance.

What changed in the third quarter?

UnitedHealth reported third-quarter revenue of USD 112.69 billion, versus USD 111.31 billion expected, while adjusted earnings per share reached USD 4.69 against USD 4.12 expected. The figures came with adjusted 2026 earnings guidance of at least USD 20.50 per share, raised from the previous USD 19.50 to USD 20.00 range, according to Yahoo Finance.

The medical care ratio was 88.4 percent in the third quarter, down from 89.9 percent a year earlier. That 1.5 percentage-point improvement helps explain why earnings advanced even as management continued to flag elevated medical utilization and investment needs.

What does the target cut mean?

Raymond James cut its price target for UnitedHealth from USD 475 to USD 450 on October 15, 2026, while maintaining an Outperform rating, Investing.com reported. The firm cited valuation and regulatory concerns around risk adjustment and Medicare quality ratings, leaving the raised earnings outlook to compete with a more cautious valuation framework.

Market value stays substantial

UnitedHealth Group had a market capitalization of USD 360.3 billion as of October 16, 2026. Its primary exchange is the NYSE, where the 52-week range was USD 255.97 to USD 461.62, placing the latest US quote below the upper end of that range.

Stock trades in pre-market

The euro reference price was EUR 357.00 at Lang & Schwarz on October 19, 2026 at 8:58 a.m. CEST, plus 0.11 percent versus the Xetra close of October 16, 2026 at EUR 356.60. The small daily move keeps the earnings revision as the central stock-specific issue, while the analyst target cut shows that valuation remains a counterweight.

The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.